TransMolecular Reports Positive Pharmacokinetic Data From Tumor Drug Study
Posted on: Wednesday, 18 June 2008, 12:00 CDT
TransMolecular has presented encouraging data from imaging and pharmacokinetic analysis of intravenous 131I-TM601 in patients with primary malignant glioma or solid tumor metastases.
Pharmacokinetic analysis revealed that 131I-TM601 rapidly clears from the blood stream and is then quickly removed from the body through the urinary system. Additionally, imaging localization analysis showed that three of five evaluable patients demonstrated tumor-specific uptake of 131I-TM601 into known areas of tumor involvement.
A subsequent analysis from this study revealed that all five glioma patients demonstrated uptake and that in a melanoma subset of this study, five out of six patients demonstrated uptake.
TM601 is a novel synthetic peptide derived from scorpion venom, which is highly specific and selective in targeting both primary tumors and metastases.
Michael Egan, president and CEO of TransMolecular, said: "These positive attributes and its favorable pharmacokinetic profile contribute to the broad promise of the TM601 platform, which also includes potential efficacy in multiple cancer types, potential for treating patients with TM601 on its own as well as linked to radiation, and utility for using TM601 to deliver other treatments directly to cancer cells."
Source: Datamonitor
Related Articles
- New Analysis Suggests That Improvements in Kidney Function in Patients Treated With Lipitor Strongly Correlate With a Reduced Risk of Major Cardiovascular Events
- 338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment
- Targeted Anticancer Drugs - In Vitro Assessment and Non-Invasive Imaging of Patient and Tumor Status Will Determine Clinical and Commercial Success
- ERBITUX(R) (Cetuximab) Data Demonstrate Improvements in Response Rate and Progression-Free Survival in Wild Type K-Ras Metastatic Colorectal Cancer Patients in First-Line Setting
- Another Step on the Journey to Hope for MDS Patients: New Study Demonstrates Survival Benefit in Patients With MDS (Myelodysplastic Syndromes)
- Effectiveness of InfoMedics Patient Feedback Programs Demonstrated at Two Health Care Industry Events
- Lipitor Significantly Reduced the Risk of Serious Cardiovascular Events Compared With Simvastatin in an 80,000-Patient Analysis of a Real-World Managed Care Database
- Analysys International Releases Five Forecasts About China's IT Market in 2006
- Analysys International Releases Five Forecasts About China's Internet and New Media Market in 2006
- The Role of Gastric Distention in Differentiating Recurrent Tumor From Physiologic Uptake in the Remnant Stomach on ^Sup 18^F-FDG PET
 |
 |
User Comments (0)
RSS Feeds